KRAS and neoplasm: Pladienolide-B inhibition of SF3B1 function not only modulated signaling cascades in tumor cells but also altered splicing of molecules crucial in PDAC, such as BCL-X, KRAS and TP53, favoring the balance of the more pro-apoptotic and/or antioncogenic variants.